“…Although endomyocardial biopsies (EMBs) may provide a definitive SC diagnosis, it presents practical limitations related to the focal nature of the disease and to the method itself, such as poor sensitivity (with diagnostic yield varying from 13 to 35%, among studies), high false negative rates, invasiveness and complications associated with tissues sampling 3,13,14,[16][17][18] .…”